<code id='BB80194E72'></code><style id='BB80194E72'></style>
    • <acronym id='BB80194E72'></acronym>
      <center id='BB80194E72'><center id='BB80194E72'><tfoot id='BB80194E72'></tfoot></center><abbr id='BB80194E72'><dir id='BB80194E72'><tfoot id='BB80194E72'></tfoot><noframes id='BB80194E72'>

    • <optgroup id='BB80194E72'><strike id='BB80194E72'><sup id='BB80194E72'></sup></strike><code id='BB80194E72'></code></optgroup>
        1. <b id='BB80194E72'><label id='BB80194E72'><select id='BB80194E72'><dt id='BB80194E72'><span id='BB80194E72'></span></dt></select></label></b><u id='BB80194E72'></u>
          <i id='BB80194E72'><strike id='BB80194E72'><tt id='BB80194E72'><pre id='BB80194E72'></pre></tt></strike></i>

          entertainment

          entertainment

          author:comprehensive    Page View:3
          A box of Sudafed PE sinus pressure and pain medicine. -- health coverage from stat
          PATRICK T. FALLON/AFP via Getty Images

          You would have been forgiven for being surprised on Sept. 12 when a panel of advisers to the Food and Drug Administration concluded that the active ingredient in Sudafed PE and other over-the-counter decongestants is completely ineffective. It was front-page news, birthed myriad explainer stories on the internet, and even inspired a lawsuit against companies that sold the medicine, phenylephrine.

          Yet when T.J. Parker, the entrepreneur and pharmacist who sold PillPack to Amazon, saw the news, he tweeted, “Didn’t everyone know this?”

          advertisement

          He had a point.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Virginia high school admissions case could be legal follow
          Virginia high school admissions case could be legal follow

          3:24DemonstratorsprotestoutsideoftheSupremeCourtinWashington,Thursday,June29,2023,aftertheSupremeCou

          read more
          AstraZeneca bets AAV gene therapy will still deliver the goods
          AstraZeneca bets AAV gene therapy will still deliver the goods

          AlastairGrant/APSengChenghasbeenworkingingenetherapyfornearlyaslongasgenetherapyhasbeenafield.Asayou

          read more
          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more

          Why Sanofi got shellacked over its spinoff

          KristofferTripplaar/SipaviaAPImagesSanofi,theParis-baseddruggiant,announcedFridaythatitwouldspinouti